Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-38,000
Closed -$2.84M 256
2022
Q4
$2.84M Sell
38,000
-2,400
-6% -$171K 0.19% 175
2022
Q3
$2.61M Sell
40,400
-800
-2% -$55.4K 0.18% 164
2022
Q2
$2.85M Sell
41,200
-900
-2% -$66.8K 0.17% 165
2022
Q1
$3.23M Buy
42,100
+6,100
+17% +$439K 0.17% 172
2021
Q4
$2.76M Sell
36,000
-1,500
-4% -$110K 0.16% 219
2021
Q3
$2.77M Sell
37,500
-700
-2% -$52.5K 0.17% 217
2021
Q2
$2.55M Buy
38,200
+700
+2% +$46.8K 0.14% 235
2021
Q1
$2.79M Buy
+37,500
New +$2.85M 0.16% 223

Other funds holding HOLX

Hennessy Advisors Inc's HOLX Position: Q1 2023 in Review

Hennessy Advisors Inc sold out of Hologic (HOLX) in Q1 2023, closing a stake of 38,000 shares — an estimated $2.84M sold.

Hennessy Advisors Inc first reported a position in HOLX in Q1 2021 and held it in 8 quarters. The position peaked at $3.23M in Q1 2022. 708 funds tracked by Wall St. Rank hold HOLX as of Q1 2023.

  • Hennessy Advisors Inc reported no remaining Hologic position as of Q1 2023 after selling out during the quarter.
  • Hennessy Advisors Inc sold 38,000 Hologic shares in Q1 2023, an estimated $2.84M.
  • Hennessy Advisors Inc first reported a position in Hologic in Q1 2021 and held it in 8 quarters.
  • Hennessy Advisors Inc's Hologic position peaked at $3.23M in Q1 2022.
  • 708 funds tracked by Wall St. Rank held Hologic as of Q1 2023.

Based on Hennessy Advisors Inc's 13F filing for Q1 2023, filed 14 Apr 2023.